-
-
Available Formats
- Options
- Availability
- Priced From ( in USD )
-
Available Formats
-
- Secure PDF 🔒
- Immediate download
- $215.00
- Add to Cart
-
- Printed Edition
- Ships in 1-2 business days
- $215.00
- Add to Cart
-
- Printed Edition + PDF
- Immediate download
- $289.00
- Add to Cart
Customers Who Bought This Also Bought
-
NSF/ANSI 53-2023
Priced From $446.00 -
NSF/ANSI 62-2023
Priced From $253.00 -
NSF/ANSI 455-4-2022
Priced From $215.00 -
NSF/ANSI 455-2-2022
Priced From $215.00
About This Item
Full Description
This standard is intended to define a standardized approach for auditing to determine the level of compliance of over-the-counter (OTC) drug products to 21 CFR Part 210 and 21 CFR Part 211, International Council for Harmonisation of Technical Requirements for Pharmaceutical for Human Use (ICH) Quality Guidelines, 1, 7 and 10, as well as incorporating additional retailer requirements.
Document History
-
NSF/ANSI 455-4-2022
viewing
Good Manufacturing Practices for Over-the-Counter Drugs- Most Recent
-
NSF/ANSI 455-4-2021
Good Manufacturing Practices for Over-the-Counter Drugs- Historical Version
-
NSF/ANSI 455-4-2020
Good Manufacturing Practices for Over-the-Counter Drugs- Historical Version
-
NSF/ANSI 455-4-2018
Good Manufacturing Practices for Over-the-Counter Drugs- Historical Version